| Ticker Details |
|
Caribou Biosciences, Inc.
|
| IPO Date: |
July 23, 2021 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$210.26M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.25 | 3.80%
|
| Avg Daily Range (30 D): |
$0.06 | 2.76%
|
| Avg Daily Range (90 D): |
$0.06 | 3.48%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
1.17M |
| Avg Daily Volume (30 D): |
1.32M |
| Avg Daily Volume (90 D): |
1.23M |
| Trade Size |
| Avg Trade Size (Sh.): |
145 |
| Avg Trade Size (Sh.) (30 D): |
192 |
| Avg Trade Size (Sh.) (90 D): |
205 |
| Institutional Trades |
| Total Institutional Trades: |
515 |
| Avg Institutional Trade: |
$1.74M |
| Avg Institutional Trade (30 D): |
$.71M |
| Avg Institutional Trade (90 D): |
$.71M |
| Avg Institutional Trade Volume: |
.28M |
| Avg Institutional Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$1.87M |
| Avg Closing Trade (30 D): |
$1.43M |
| Avg Closing Trade (90 D): |
$1.43M |
| Avg Closing Volume: |
303.05K |
|
|
| Financials |
| |
TTM |
Q4 2025 |
FY 2025 |
|
Basic EPS
|
$-.26
|
$-.28
|
$-1.59
|
|
Diluted EPS
|
$-.26
|
$-.28
|
$-1.59
|
|
Revenue
|
$2.4M
|
$3.94M
|
$11.16M
|
|
Gross Profit
|
|
|
|
|
Net Income / Loss
|
$-25.09M
|
$-26.49M
|
$-148.13M
|
|
Operating Income / Loss
|
$-26.28M
|
$-28.45M
|
$-148.34M
|
|
Cost of Revenue
|
|
|
|
|
Net Cash Flow
|
$-.3M
|
$1.22M
|
$-3.93M
|
|
PE Ratio
|
|
|
|
|
|
|